Previous 10 | Next 10 |
SCWorx (WORX) +100%.Professional Diversity Network (IPDN) +25%.Apex Technology Acquisition (APXT) +20%.Genfit SA (GNFT) +18%.Xinyuan Real Estate (XIN) +17% on Q3 results.Rhythm Pharmaceuticals (RYTM) +16% as FDA OKs it's Imcivree for weight management in obese patients.Shi...
DBV Technologies (DBVT) announced that Hugh Sampson has decided to step down from his role as chief scientific officer, or CSO, at DBV, effective December 1, to return to his research program at the Jaffe Food Allergy Institute at Mount Sinai.While acting as CSO, Sampson continued his co...
DBV Technologies (DBVT) announces that Dr. Hugh Sampson has decided to step down from his role as Chief Scientific Officer ((CSO)), effective December 1, 2020, to return to his research program at the Jaffe Food Allergy Institute at Mount Sinai.Dr. Sampson will take on a new role as Scientifi...
Danaos (DAC) -19%.Renren (RENN) -11%.DBV Technologies (DBVT) -10% after announcing leadership changesSilvercorp Metals (SVM) -9% after TLP, LME, LMW and HPG mines in the Ying Mining District, Henan Province, and GC mine, Guangdong Province, have been certified as ...
Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2020 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris ISIN C...
Montrouge, France, November 10, 2020 DBV Technologies to Highlight Data on Viaskin ™ Peanut Treatment Delivery and Patient Experience at ACAAI 2020 Meeting also will feature virtual industry symposium on managing food allergies amid the COVID-19 pandemic DBV...
Montrouge, France, November 9, 2020 DBV Technologies to Participate in Upcoming Investor Conferences DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced its participation in th...
Hall of Fame Resort & Entertainment (HOFV) +90% on partnership agreement with WaV and Sports Illustrated Studio.Kaixin Auto Holdings (KXIN) +62% on entering into a binding term sheet with Haitaoche Limited.Altus Midstream Company (ALTM) +52% on Q3 results.Upw...
Are These The Best Penny Stocks To Buy Right Now? Are penny stocks part of your investing and trading strategy? If they’re not, you might want to reconsider. While plenty of these stocks under $5 are highly volatility and many end up failing, there’s a whole other side...
Gainers: Inspire Medical Systems (INSP) +24%, GW Pharmaceuticals (GWPH) +15%, Aptevo Therapeutics (APVO) +14%, Galera Therapeutics (GRTX) +11%, DBV Technologies (DBVT) +10%.Losers: Esperion Therapeutics (ESPR) -15%, Aurinia Pharmaceuticals (AUPH)...
News, Short Squeeze, Breakout and More Instantly...
DBV Technologies S.A. Company Name:
DBVT Stock Symbol:
NASDAQ Market:
DBV Technologies S.A. Website:
Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2024 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris ISIN Code: FR 0010417345 ...
Châtillon, France, July 30, 2024 DBV Technologies Announces Filing of 2024 Half-Year Report ― Conditions for Accessing or Consulting the Report DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutic...
Châtillon, France, July 30, 2024 DBV Technologies Provides Updates on the Viaskin Peanut Program in Children and Toddlers and Reports Second Quarter and Half-Year 2024 Financial Results VITESSE enrollment in peanut allergic 4-7-year-olds is on-track and recruitment is expecte...